STE vs TECX · P/E 25, rev $5.46B vs $567.2M cap
STERIS plc (STE) versus Tectonic Therapeutic, Inc. (TECX) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Tectonic Therapeutic, Inc. (TECX) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
TECX does not have a complete income-statement cache yet.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TECX currently screens at market cap $567.2M.
Not investment advice. Open the STE and TECX stock pages for the full models.
Not investment advice.